Literature DB >> 22891109

Liposomes in diagnosis and treatment of cardiovascular disorders.

Tatyana S Levchenko1, William C Hartner, Vladimir P Torchilin.   

Abstract

Entities:  

Keywords:  PEGylated liposomes; cardiovascular disease; immunoliposomes ; liposomal drug delivery; liposomes; myocardial infarction; nanocarriers

Mesh:

Substances:

Year:  2012        PMID: 22891109      PMCID: PMC3405779          DOI: 10.14797/mdcj-8-1-36

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


× No keyword cloud information.
  60 in total

1.  In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement.

Authors:  S M Demos; H Onyüksel; J Gilbert; S I Roth; B Kane; P Jungblut; J V Pinto; D D McPherson; M E Klegerman
Journal:  J Pharm Sci       Date:  1997-02       Impact factor: 3.534

2.  ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction.

Authors:  Daya D Verma; William C Hartner; Tatayana S Levchenko; Eugene A Bernstein; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2005-11-05       Impact factor: 4.200

3.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

4.  Development and physico-chemical characterization of a liposomal formulation of istaroxime.

Authors:  Paola Luciani; Maréva Fevre; Jean-Christophe Leroux
Journal:  Eur J Pharm Biopharm       Date:  2011-04-29       Impact factor: 5.571

5.  Apoptosis is initiated by myocardial ischemia and executed during reperfusion.

Authors:  B Freude; T N Masters; F Robicsek; A Fokin; S Kostin; R Zimmermann; C Ullmann; S Lorenz-Meyer; J Schaper
Journal:  J Mol Cell Cardiol       Date:  2000-02       Impact factor: 5.000

6.  An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.

Authors:  Yoshiko Uesugi; Hiroyuki Kawata; Jun-ichiro Jo; Yoshihiko Saito; Yasuhiko Tabata
Journal:  J Control Release       Date:  2010-08-06       Impact factor: 9.776

7.  Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study.

Authors:  Shuhua Bai; Vivek Gupta; Fakhrul Ahsan
Journal:  Eur J Pharm Sci       Date:  2009-07-16       Impact factor: 4.384

8.  Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide.

Authors:  Y T Ko; W C Hartner; A Kale; V P Torchilin
Journal:  Gene Ther       Date:  2008-08-14       Impact factor: 5.250

9.  Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase.

Authors:  J Kent Leach; Edgar A O'Rear; Eugene Patterson; Yiwei Miao; Arthur E Johnson
Journal:  Thromb Haemost       Date:  2003-07       Impact factor: 5.249

10.  Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.

Authors:  Andrei Maiseyeu; Georgeta Mihai; Thomas Kampfrath; Orlando P Simonetti; Chandan K Sen; Sashwati Roy; Sanjay Rajagopalan; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

View more
  6 in total

Review 1.  Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration.

Authors:  Diana Gonciar; Teodora Mocan; Lucia Agoston-Coldea
Journal:  Pharmaceutics       Date:  2022-03-26       Impact factor: 6.525

2.  Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.

Authors:  Siva Sai Krishna Dasa; Ryo Suzuki; Emily Mugler; Lanlin Chen; Rasmus Jansson-Löfmark; Erik Michaëlsson; Lennart Lindfors; Alexander L Klibanov; Brent A French; Kimberly A Kelly
Journal:  Nanomedicine       Date:  2017-07-25       Impact factor: 5.307

Review 3.  Tissue plasminogen activator-based clot busting: Controlled delivery approaches.

Authors:  Ibrahim M El-Sherbiny; Islam E Elkholi; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16

4.  High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer.

Authors:  Ievgen V Pylypchuk; Huizhen Suo; Chanakarn Chucheepchuenkamol; Nils Jedicke; Pär A Lindén; Mikael E Lindström; Michael P Manns; Olena Sevastyanova; Tetyana Yevsa
Journal:  Front Bioeng Biotechnol       Date:  2022-02-07

Review 5.  Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases.

Authors:  Mehak Passi; Sadia Shahid; Sankarakuttalam Chockalingam; Isaac Kirubakaran Sundar; Gopinath Packirisamy
Journal:  Int J Nanomedicine       Date:  2020-05-28

6.  Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.

Authors:  Ahmed Al-Darraji; Renée R Donahue; Himi Tripathi; Hsuan Peng; Bryana M Levitan; Lakshman Chelvarajan; Dalia Haydar; Erhe Gao; David Henson; John C Gensel; David J Feola; Vincent J Venditto; Ahmed Abdel-Latif
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.